Rare Disease Drug FIRDAPSE Protected Until 2035: Catalyst Pharma Wins Patent Settlement with Lupin – Stock Titan

Rare Disease Drug FIRDAPSE Protected Until 2035: Catalyst Pharma Wins Patent Settlement with Lupin  Stock Titan